| Dr Erika J Siska, MD | |
|
777 76th Avenue Dr Sw, Cedar Rapids, IA 52404-7006 | |
| (319) 558-0355 | |
| Not Available |
| Full Name | Dr Erika J Siska |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 22 Years |
| Location | 777 76th Avenue Dr Sw, Cedar Rapids, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750583605 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35999 (Iowa) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD-35999 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Medical Center - Cedar Rapids | Cedar rapids, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Medical Center | 4183535271 | 165 |
News Archive
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
King Pharmaceuticals, Inc. has reported the receipt by its Meridian Technologies subsidiary of a letter from the U.S. Food and Drug Administration
› Verified 5 days ago
| Entity Name | Mercy Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700834165 PECOS PAC ID: 4183535271 Enrollment ID: O20031215000145 |
News Archive
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
King Pharmaceuticals, Inc. has reported the receipt by its Meridian Technologies subsidiary of a letter from the U.S. Food and Drug Administration
› Verified 5 days ago
| Entity Name | Mercy Physician Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427254952 PECOS PAC ID: 1355242496 Enrollment ID: O20040120000805 |
News Archive
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
King Pharmaceuticals, Inc. has reported the receipt by its Meridian Technologies subsidiary of a letter from the U.S. Food and Drug Administration
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erika J Siska, MD 700 Whiting Ave, Iowa City, IA 52245-5643 Ph: (319) 325-7751 | Dr Erika J Siska, MD 777 76th Avenue Dr Sw, Cedar Rapids, IA 52404-7006 Ph: (319) 558-0355 |
News Archive
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
King Pharmaceuticals, Inc. has reported the receipt by its Meridian Technologies subsidiary of a letter from the U.S. Food and Drug Administration
› Verified 5 days ago
Dr. Stephanie Colleen Jackson, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 275 10th St Se Ste 3320, Cedar Rapids, IA 52403 Phone: 319-398-1721 | |
Dr. Dorthea Lorine Wheeler, MD, PHD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1730 1st Ave Ne, Cedar Rapids, IA 52402 Phone: 319-365-3993 | |
Jennifer Ann Donovan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1201 3rd Ave Se, Eastern Iowa Health Center, Cedar Rapids, IA 52403 Phone: 319-730-7300 Fax: 319-730-7368 | |
Allyson L Wheaton, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1730 1st Ave Ne, Cedar Rapids, IA 52402 Phone: 319-365-3993 Fax: 319-364-0116 | |
Alan Whitters, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3705 River Ridge Dr Ne, Cedar Rapids, IA 52402 Phone: 319-393-0004 Fax: 319-393-0900 | |
Jeniece Nott, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1730 1st Ave Ne, Cedar Rapids, IA 52402 Phone: 319-365-3993 | |
Mr. Winthrop S Risk Ii, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 811 5th Ave Se, Cedar Rapids, IA 52403 Phone: 319-362-7924 Fax: 319-362-1435 |